These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31724465)

  • 1. Antiviral bioactivity of renewable polysaccharides against
    Abu-Galiyun E; Huleihel M; Levy-Ontman O
    Cell Cycle; 2019 Dec; 18(24):3540-3549. PubMed ID: 31724465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of propolis special extract GH 2002 against
    Labská K; Plodková H; Pumannová M; Sensch KH
    Pharmazie; 2018 Dec; 73(12):733-736. PubMed ID: 30522559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus.
    Miwa N; Kurosaki K; Yoshida Y; Kurokawa M; Saito S; Shiraki K
    Antiviral Res; 2005 Jan; 65(1):49-55. PubMed ID: 15652971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral drugs for varicella-zoster virus and herpes simplex virus infections.
    Med Lett Drugs Ther; 2018 Sep; 60(1556):153-157. PubMed ID: 30383727
    [No Abstract]   [Full Text] [Related]  

  • 5. Titration of cell-associated varicella-zoster virus with the MV9G reporter cell line for antiviral studies.
    Li X; Li X; Gong W; Wang G; Lu Z; Wu N; Lian C; Huang L; Inoue N
    J Virol Methods; 2018 Oct; 260():14-20. PubMed ID: 29966597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro.
    Baba M; Shigeta S
    Antiviral Res; 1987 Feb; 7(2):99-107. PubMed ID: 3034150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication.
    Visalli RJ; Fairhurst J; Srinivas S; Hu W; Feld B; DiGrandi M; Curran K; Ross A; Bloom JD; van Zeijl M; Jones TR; O'Connell J; Cohen JI
    J Virol; 2003 Feb; 77(4):2349-58. PubMed ID: 12551972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV.
    Hasegawa T; Kurokawa M; Yukawa TA; Horii M; Shiraki K
    Antiviral Res; 1995 Jun; 27(3):271-9. PubMed ID: 8540749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus.
    Shiraki K; Ochiai H; Namazue J; Okuno T; Ogino S; Hayashi K; Yamanishi K; Takahashi M
    Antiviral Res; 1992 Jun; 18(2):209-14. PubMed ID: 1329651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of BV-araU and acyclovir on varicella-zoster virus replication with various length and timing of drug exposure.
    Machida H; Nishitani M; Ashida N
    Microbiol Immunol; 1994; 38(2):109-15. PubMed ID: 8041297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline.
    Knechtel ML; Huang A; Vaillancourt VA; Brideau RJ
    J Med Virol; 2002 Oct; 68(2):234-6. PubMed ID: 12210413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro.
    Sasivimolphan P; Lipipun V; Likhitwitayawuid K; Takemoto M; Pramyothin P; Hattori M; Shiraki K
    Antiviral Res; 2009 Oct; 84(1):95-7. PubMed ID: 19635502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Features of Varicella-Zoster Virus Infection.
    Kennedy PGE; Gershon AA
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30400213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an anti-varicella-zoster virus compound that targets the portal protein encoded by ORF54.
    Yasui R; Yoshida C; Yamaguchi T; Inoue N
    Microbiol Immunol; 2017 Sep; 61(9):398-402. PubMed ID: 28833387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of liquorice powder extract against varicella zoster virus isolated from Egyptian patients.
    Shebl RI; Amin MA; Emad-Eldin A; Bin Dajem SM; Mostafa AS; Ibrahim EH; Mohamed AF
    Chang Gung Med J; 2012; 35(3):231-9. PubMed ID: 22735054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic anti-varicella-zoster virus activity of interferon-alpha 2a and acyclovir in corneal cells.
    Punda-Polić V; O'Brien WJ; Taylor JL
    Zentralbl Bakteriol; 1999 Apr; 289(2):203-10. PubMed ID: 10360320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
    Standring-Cox R; Bacon TH; Howard BA
    J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effects of Cacicol
    Deback C; Rousseau A; Breckler M; Molet L; Boutolleau D; Burrel S; Roque-Afonso AM; Labetoulle M
    Antivir Ther; 2018; 23(8):665-675. PubMed ID: 30028308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of varicella-zoster virus to acyclovir.
    Biron KK; Elion GB
    Antimicrob Agents Chemother; 1980 Sep; 18(3):443-7. PubMed ID: 6252836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.